Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
BMC Infect Dis
.
2021 Sep 16;21(1):962.
doi: 10.1186/s12879-021-06671-x.
Authors
Yvette N Löwensteyn
1
,
Natalie I Mazur
1
,
Harish Nair
2
3
,
Joukje E Willemsen
1
,
Ghislaine van Thiel
4
,
Louis Bont
5
6
;
RSV GOLD III—ICU Network Study Group
Collaborators
RSV GOLD III—ICU Network Study Group
:
Maria Ahuoiza Garba
,
Fatima Jumai Giwa
,
Mohammad Hafiz Rasooly
,
Aminullah Shirpoor
,
Merwais Azizyar
,
Lamin Makalo
,
Ousman Nyan
,
Ali Mohamed
,
Khalid Osman
,
Ram Hari Chapagain
,
Krishna Prasad Bista
,
Arun Kumar Sharma
,
Prabina Shrestha
,
Bamenla Goka
,
Kwabena Osman
,
Evangeline Obodai
,
Henshaw Mandi
,
Lucas Esuh Esong
,
Charlotte Ekoube Eposse
,
Valéria Muando
,
Tufária Mussá
,
Yasser Habresh Said
,
Aika Abia Shoo
,
Vanessa Jaelle Dor
,
Jacqueline Gautier
,
Lynda Abicher
Affiliations
1
Division of Infectious Diseases, Department of Paediatrics, University Medical Centre Utrecht, Utrecht, The Netherlands.
2
Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
3
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, The Netherlands.
4
Julius Center for Health Sciences and Primary Care, Medical Humanities Department, University Medical Center Utrecht, Utrecht, The Netherlands.
5
Division of Infectious Diseases, Department of Paediatrics, University Medical Centre Utrecht, Utrecht, The Netherlands. l.bont@umcutrecht.nl.
6
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, The Netherlands. l.bont@umcutrecht.nl.
PMID:
34530766
PMCID:
PMC8447746
DOI:
10.1186/s12879-021-06671-x
No abstract available
Publication types
Published Erratum